Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma - Related Studies

Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma

This study is ongoing, but not recruiting participants.

Study NCT00002599. Last updated on August 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Multiple Myeloma
		Neoplasms, Plasma Cell

2	More general conditions related to this trial
		Blood Protein Disorders
		Cardiovascular Diseases
		Hematologic Diseases
		Hemorrhagic Disorders
		Hemostatic Disorders
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type
		Paraproteinemias
		Vascular Diseases

3	Interventions listed in this trial
		carmustine
		cyclophosphamide
		doxorubicin hydrochloride
		filgrastim
		melphalan
		methylprednisolone
		prednisone
		recombinant interferon alfa
		sargramostim
		vincristine sulfate
		low-LET cobalt-60 gamma ray therapy
		low-LET photon therapy

4	Additional drug interventions recognized in this trial
		Doxorubicin
		Interferon Alfa-2a
		Interferon Type I, Recombinant
		Interferon-alpha
		Interferons
		Methylprednisolone acetate
		Methylprednisolone Hemisuccinate
		Prednisolone
		Prednisolone acetate
		Vincristine

5	More general drug interventions related to this trial
		Alkylating Agents
		Angiogenesis Inhibitors
		Angiogenesis Modulating Agents
		Anti-Infective Agents
		Anti-Inflammatory Agents
		Antibiotics, Antineoplastic
		Antiemetics
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antineoplastic Agents, Hormonal
		Antineoplastic Agents, Phytogenic
		Antirheumatic Agents
		Antiviral Agents
		Autonomic Agents
		Central Nervous System Agents
		Gastrointestinal Agents
		Glucocorticoids
		Growth Inhibitors
		Growth Substances
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Immunologic Factors
		Immunosuppressive Agents
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Neuroprotective Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Protective Agents
		Therapeutic Uses
		Tubulin Modulators

6	Sponsors listed in this trial
		Medical Research Council